Evan Seigerman, BMO senior analyst, joins 'Closing Bell Overtime' to talk today's Capitol Hill hearing with Novo Nordisk's ...

Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk CEO defending GLP-1 pricing and the push to lower prices.

Employers that cover GLP-1s are partnering with vendors to design benefits and manage lifestyle programs, but the "jury is ...

Anti-obesity medication is emerging as the latest pharma megatrend. However, the increasing demand for these semaglutide ...

Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

It's a big day for Novo Nordisk (NVO) as its CEO Lars Fruergaard Jørgensen testified Tuesday on Capitol Hill over the ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will testify at a Senate hearing today about the prices of Ozempic and Wegovy.

Novo Nordisk's CEO faced lawmakers in a grueling 2.5-hour hearing to discuss the cost of blockbuster drugs Ozempic and Wegovy ...

Now, green tea has followed the inevitable trajectory of any weight loss trick: It’s getting big on TikTok. Viral videos ...

While several factors predict sustained glycemic control, predictors of sustained weight control with tirzepatide appear ...

When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...